FY21 Result: The result today were marginally lower than consensus expectations however the year on year growth was impressive all the same, a clear COVID beneficiary that is playing a key role in testing & pathology. The market looks forward and clearly the outlook for FY22 is for slower growth and it seemed like that was the focus today. Not a stock we own however the ~7% pullback today has us reviewing more closely.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Performance update for March, stocks that drove returns & our current positioning
Close
Wednesday 24th April – ASX200 +17pts, Silver Lake (SLR), Kogan (KGN) & CPI
Close
Market Matters Research Lead Shawn Hickman with David Koch
Close
Wednesday 24th April – DOW +263pts, SPI +27pts
Close
Related Q&A
Thoughts please on HLS & MCR after bids
Thoughts on – CAJ, HLS & ING please?
Does MM like healthcare stocks HLS & CAJ?
Picking a healthcare winner
Technical thoughts on CGF & HLS
Q’s on CSR, BLD, TAH, HLS
Relevant suggested news and content from the site
Video
WATCH
Performance update for March, stocks that drove returns & our current positioning
Recorded Tuesday 9th April
Podcast
LISTEN
Wednesday 24th April – ASX200 +17pts, Silver Lake (SLR), Kogan (KGN) & CPI
Daily Podcast Direct from the Desk
Video
WATCH
Market Matters Research Lead Shawn Hickman with David Koch
Recorded Monday 25th March
Podcast
LISTEN
Wednesday 24th April – DOW +263pts, SPI +27pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.